Market Closed -
Other stock markets
|
After market 12:45:52 pm | |||
0.9 EUR | +2.16% | 0.898 | -0.22% |
Apr. 22 | Pharming Group to Buy Back EUR123 Million of Bonds due 2025 | MT |
Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
Sales 2024 * | 262M 281M | Sales 2025 * | 300M 323M | Capitalization | 593M 637M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.07M | Net income 2025 * | 14M 15.04M | EV / Sales 2024 * | 1.92 x |
Net cash position 2024 * | 90.86M 97.6M | Net cash position 2025 * | 119M 128M | EV / Sales 2025 * | 1.58 x |
P/E ratio 2024 * |
-294
x | P/E ratio 2025 * |
40
x | Employees | 382 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Pharming Group N.V.
1 day | +1.87% | ||
1 week | +1.87% | ||
Current month | -11.92% | ||
1 month | -11.31% | ||
3 months | -22.70% | ||
6 months | -18.04% | ||
Current year | -12.95% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.05% | 7 M€ | -.--% | - | |
0.02% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.9 | +2.16% | 3 641 122 |
24-04-25 | 0.881 | -2.60% | 4,203,859 |
24-04-24 | 0.9045 | -0.39% | 6,519,524 |
24-04-23 | 0.908 | +0.89% | 4,300,077 |
24-04-22 | 0.9 | +2.16% | 6,570,354 |
Real-time Euronext Amsterdam, April 26, 2024 at 05:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.95% | 636M | |
+24.85% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.41% | 233B | |
+5.56% | 201B | |
-10.10% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- PHARM Stock